ID: ALA5208089

Max Phase: Preclinical

Molecular Formula: C14H13N3OS2

Molecular Weight: 303.41

Associated Items:

Representations

Canonical SMILES:  CC1CCc2c(sc(NC(=O)c3cscn3)c2C#N)C1

Standard InChI:  InChI=1S/C14H13N3OS2/c1-8-2-3-9-10(5-15)14(20-12(9)4-8)17-13(18)11-6-19-7-16-11/h6-8H,2-4H2,1H3,(H,17,18)

Standard InChI Key:  TYDHZPHOQLAMKG-UHFFFAOYSA-N

Associated Targets(Human)

143B 353 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 303.41Molecular Weight (Monoisotopic): 303.0500AlogP: 3.45#Rotatable Bonds: 2
Polar Surface Area: 65.78Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.06CX Basic pKa: CX LogP: 3.78CX LogD: 3.78
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.92Np Likeness Score: -2.64

References

1. Jin W, Zhang T, Zhou W, He P, Sun Y, Hu S, Chen H, Ma X, Peng Y, Yi Z, Liu M, Chen Y..  (2022)  Discovery of 2-Amino-3-cyanothiophene Derivatives as Potent STAT3 Inhibitors for the Treatment of Osteosarcoma Growth and Metastasis.,  65  (9.0): [PMID:35476936] [10.1021/acs.jmedchem.2c00004]

Source